Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 16/20 | 0.55 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10314510 | 0.88 | PTPN1 (0.44) | SELP | |
| SCHEMBL12228815 | 0.86 | SELP (0.48) | SELP | |
| SCHEMBL1170806 | 0.84 | SELP (0.53) | SELP | |
| SCHEMBL1170807 | 0.84 | SELP (0.53) | SELP | |
| SCHEMBL1170808 | 0.84 | SELP (0.53) | SELP | |
| SCHEMBL12227936 | 0.84 | SELP (0.46) | SELPPLA2G4A | |
| SCHEMBL12228315 | 0.82 | SELP (0.44) | SELP | |
| SCHEMBL12228221 | 0.79 | SELP (0.43) | SELPPLA2G4A | |
| SCHEMBL1170786 | 0.79 | SELP (0.56) | SELPPLA2G4A | |
| SCHEMBL1170905 | 0.79 | SELP (0.58) | SELPPLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008047249-A9 | ALPHA-GALACTOCERAMIDE ANALOGS, THEIR METHODS OF MANUFACTURE, INTERMEDIATE COMPOUNDS USEFUL IN THESE METHODS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-12-23 | — | — | WO | disclosed |
| WO-2008047249-A2 | ALPHA-GALACTOCERAMIDE ANALOGS, THEIR METHODS OF MANUFACTURE, INTERMEDIATE COMPOUNDS USEFUL IN THESE METHODS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-04-24 | — | — | WO | disclosed |